Kimoto E[au] - Search Results

Year	Number of Results
1954	1
1964	1
1965	1
1966	1
1968	1
1969	1
1970	1
1971	5
1972	2
1974	3
1975	1
1977	1
1978	1
1979	2
1981	1
1982	5
1983	4
1984	4
1985	2
1986	3
1987	2
1988	4
1989	3
1990	3
1991	3
1992	1
1993	5
1994	8
1995	2
1996	6
1997	2
1999	1
2000	2
2001	1
2002	3
2003	3
2004	3
2005	2
2006	4
2007	2
2008	1
2009	3
2010	5
2011	5
2012	7
2013	3
2014	3
2015	2
2016	2
2017	8
2018	10
2019	6
2020	6
2021	6
2022	4
2023	2

1

Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans.

Eng H, Dantonio AL, Kadar EP, Obach RS, Di L, Lin J, Patel NC, Boras B, Walker GS, Novak JJ, Kimoto E, Singh RSP, Kalgutkar AS. Eng H, et al. Among authors: kimoto e. Drug Metab Dispos. 2022 May;50(5):576-590. doi: 10.1124/dmd.121.000801. Epub 2022 Feb 13. Drug Metab Dispos. 2022. PMID: 35153195

2

Percutaneous cholecystoscopy.

Inui K, Nakazawa S, Yoshino J, Yamao K, Naito Y, Kimoto E, Asai T. Inui K, et al. Among authors: kimoto e. Endoscopy. 1989 Dec;21 Suppl 1:361-4. doi: 10.1055/s-2007-1012991. Endoscopy. 1989. PMID: 2606086

3

Identification and quantitation of enzyme and transporter contributions to hepatic clearance for the assessment of potential drug-drug interactions.

Kimoto E, Obach RS, Varma MVS. Kimoto E, et al. Drug Metab Pharmacokinet. 2020 Feb;35(1):18-29. doi: 10.1016/j.dmpk.2019.11.007. Epub 2019 Dec 20. Drug Metab Pharmacokinet. 2020. PMID: 31952912 Review.

4

[Squamous cell carcinoma of the extrahepatic bile duct].

Funakawa T, Fujishiro N, Kuno N, Kobayashi S, Kimoto E, Suzuki K. Funakawa T, et al. Among authors: kimoto e. Ryoikibetsu Shokogun Shirizu. 1996;(9):61-3. Ryoikibetsu Shokogun Shirizu. 1996. PMID: 8705560 Review. Japanese. No abstract available.

5

In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation.

Bi YA, Kimoto E, Sevidal S, Jones HM, Barton HA, Kempshall S, Whalen KM, Zhang H, Ji C, Fenner KS, El-Kattan AF, Lai Y. Bi YA, et al. Among authors: kimoto e. Drug Metab Dispos. 2012 Jun;40(6):1085-92. doi: 10.1124/dmd.111.043489. Epub 2012 Mar 1. Drug Metab Dispos. 2012. PMID: 22381335 Review.

6

Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.

Lai Y, Varma M, Feng B, Stephens JC, Kimoto E, El-Kattan A, Ichikawa K, Kikkawa H, Ono C, Suzuki A, Suzuki M, Yamamoto Y, Tremaine L. Lai Y, et al. Among authors: kimoto e. Expert Opin Drug Metab Toxicol. 2012 Jun;8(6):723-43. doi: 10.1517/17425255.2012.678048. Epub 2012 Apr 18. Expert Opin Drug Metab Toxicol. 2012. PMID: 22509796 Review.

7

Physiologically-Based Pharmacokinetic Modeling Approach to Predict Rifampin-Mediated Intestinal P-Glycoprotein Induction.

Yamazaki S, Costales C, Lazzaro S, Eatemadpour S, Kimoto E, Varma MV. Yamazaki S, et al. Among authors: kimoto e. CPT Pharmacometrics Syst Pharmacol. 2019 Sep;8(9):634-642. doi: 10.1002/psp4.12458. Epub 2019 Sep 5. CPT Pharmacometrics Syst Pharmacol. 2019. PMID: 31420942 Free PMC article.

8

Biomarker-Informed Model-Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug-Drug Interactions.

Kimoto E, Costales C, West MA, Bi YA, Vourvahis M, David Rodrigues A, Varma MVS. Kimoto E, et al. Clin Pharmacol Ther. 2022 Feb;111(2):404-415. doi: 10.1002/cpt.2434. Epub 2021 Oct 22. Clin Pharmacol Ther. 2022. PMID: 34605015

9

Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease.

Vildhede A, Kimoto E, Pelis RM, Rodrigues AD, Varma MVS. Vildhede A, et al. Among authors: kimoto e. Clin Pharmacol Ther. 2020 May;107(5):1128-1137. doi: 10.1002/cpt.1699. Epub 2019 Dec 26. Clin Pharmacol Ther. 2020. PMID: 31630405

10

Analysis of ascorbic acid, dehydroascorbic acid, and transformation products by ion-pairing high-performance liquid chromatography with multiwavelength ultraviolet and electrochemical detection.

Kimoto E, Terada S, Yamaguchi T. Kimoto E, et al. Methods Enzymol. 1997;279:3-12. doi: 10.1016/s0076-6879(97)79003-7. Methods Enzymol. 1997. PMID: 9211251 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

159 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year